Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Short-term Investments (2020 - 2021)

Design Therapeutics' Short-term Investments history spans 2 years, with the latest figure at $36.1 million for Q3 2021.

  • For Q3 2021, Short-term Investments changed N/A year-over-year to $36.1 million; the TTM value through Sep 2021 reached $36.1 million, changed N/A, while the annual FY2020 figure was $47000.0, N/A changed from the prior year.
  • Short-term Investments for Q3 2021 was $36.1 million at Design Therapeutics, up from $90000.0 in the prior quarter.
  • Across five years, Short-term Investments topped out at $36.1 million in Q3 2021 and bottomed at $47000.0 in Q4 2020.